Colgate-Palmolive (NYSE:CL) Shares Acquired by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. lifted its holdings in shares of Colgate-Palmolive (NYSE:CL) by 4.5% during the 3rd quarter, Holdings Channel.com reports. The fund owned 2,884,680 shares of the company’s stock after buying an additional 123,186 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Colgate-Palmolive were worth $299,459,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in CL. E Fund Management Hong Kong Co. Ltd. acquired a new stake in shares of Colgate-Palmolive during the second quarter worth about $25,000. Continuum Advisory LLC lifted its stake in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after buying an additional 125 shares during the last quarter. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive in the third quarter valued at approximately $42,000. Gradient Investments LLC grew its position in shares of Colgate-Palmolive by 150.4% during the second quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after acquiring an additional 400 shares during the last quarter. Finally, Financial Connections Group Inc. acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at $68,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, insider Sally Massey sold 15,850 shares of the stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 43,490 shares of company stock valued at $4,486,063 in the last ninety days. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Down 0.4 %

CL opened at $93.33 on Monday. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.28 and a current ratio of 1.04. The company has a market cap of $76.25 billion, a price-to-earnings ratio of 26.74, a PEG ratio of 3.35 and a beta of 0.42. Colgate-Palmolive has a one year low of $74.22 and a one year high of $109.30. The business’s fifty day moving average is $102.26 and its two-hundred day moving average is $98.35.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $0.50 dividend. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Hsbc Global Res cut shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. JPMorgan Chase & Co. raised their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, October 29th. Redburn Atlantic upgraded Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. Finally, Citigroup lifted their price objective on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $105.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.